Riccardo Autorino, MD

• Academic leadership, surgical education, and clinical research administration across major U.S. medical centers.
• Internationally recognized for expertise in robotic and minimally invasive urologic oncology, particularly in single-port robotic surgery.
• Pioneered and refined robotic approaches for kidney, prostate, and upper tract urothelial cancers.
• Active faculty and live surgeon at leading global robotic and endourology meetings.
• Author of 600+ peer-reviewed publications in leading journals
• h-index: 88 (Google Scholar), 71 (Scopus) - reflecting sustained impact and citation leadership in urologic research.
• Principal Investigator of ROBUUST (Robotic Surgery for Upper Tract Urothelial Cancer) and Co-PI of SPARC, major international collaborative studies in robotic urology.
• Editorial board member for over 10 major urologic journals, including European Urology, European Urology Oncology, and Urology Practice.
• Top Reviewer and Outstanding Educator by leading journals and institutions.
• Invited speaker, surgeon, and course director at major international conferences (EAU, AUA, SIU, ERUS, WCET).
• Active contributor to global consensus efforts and guideline committees in robotic and oncologic urology.

Surgical Leadership Program, Harvard Medical School, Cambridge, MA, USA (2019–2021)

• Hans Marberger Award (European Association of Urology) for excellence in minimally invasive surgery research.
• Multiple Faculty Teaching Awards (Cleveland Clinic, VCU and Rush University).
• Matula Award (Italian Society of Urology)

• European Association of Urology (EAU)
• Italian Society of Urology (SIU)
• American Urological Association (AUA)
• Endourological Society
• Société Internationale d’Urologie (SIU)
• Southwest Germany Society of Urology (SWDGU)
• Association of Academic European Urologists (AAEU)
• Society of Urologic Oncology (SUO)

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-23, Dr. Autorino has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Autorino receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Intuitive Surgical, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.